ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,793.30
1.44%
S&P ASX All Technology
3,068.10
1.62%
Brent Oil
83.475
0.00%
US Dollar vs AUD
1.51473
0.33%
Bitcoin
63,659.23
0.78%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Adaptimmune Therapeutics PLC (ADAP)

  7. Adaptimmune Therapeutics PLC (ADAP) News

ADAP

Adaptimmune Therapeutics (ADAP)

Adaptimmune Therapeutics PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADAP
DateTimeSourceHeadlineSymbolCompany
06/03/202423:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
28/02/202400:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
17/02/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
01/02/202409:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
18/01/202409:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
18/01/202409:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
18/01/202409:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
18/01/202409:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
18/01/202409:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
18/01/202409:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
13/01/202409:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
13/01/202409:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
04/01/202423:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
06/12/202323:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
01/12/202308:16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ADAPAdaptimmune Therapeutics PLC
09/11/202308:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ADAPAdaptimmune Therapeutics PLC
08/11/202323:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
04/11/202307:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
31/10/202323:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
01/09/202307:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
11/08/202306:05Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ADAPAdaptimmune Therapeutics PLC
10/08/202306:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ADAPAdaptimmune Therapeutics PLC
09/08/202321:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
02/08/202307:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
06/07/202307:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
04/07/202307:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
04/07/202307:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
04/07/202307:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
30/06/202306:54Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ADAPAdaptimmune Therapeutics PLC
30/06/202306:48Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ADAPAdaptimmune Therapeutics PLC
 Showing the most relevant articles for your search:NASDAQ:ADAP

Your Recent History

ASX
AMP
AMP
NASDAQ
AAPL
Apple
NYSE
KO
Coca Cola
NYSE
VZ
Verizon Communications
ASX
XJO
S&P ASX 200
FX
AUDUSD
AUD vs US Dollar
FX
EURAUD
Euro vs AUD
ASX
WDC
Westfield
FX
AUDCAD
AUD vs CAD
ASX
RIO
Rio Tinto
ASX
NAB
National Australia Bank
ASX
XTO
S&P ASX 100
PM
XAUUSD
Gold vs US Dollar
COIN
BTCUSD
Bitcoin
ASX
WOW
Woolworths
ASX
WPL
Woodside Petroleum
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved